Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Alzheimer Disease

New blood test could detect Alzheimer’s disease 3.5 years before diagnosis – study

Research supports idea that components in human blood can influence formation of new brain cells

The Independent UK

New test 'could detect Alzheimer’s disease 3.5 years before diagnosis'

Researchers establish a blood-based test that could predict risk of the condition at an earlier stage

Wales Online

New test could detect Alzheimer’s disease 3.5 years before diagnosis – study

The research supports the idea that components in human blood can influence the formation of new brain cells.

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Possible link between Alzheimer's disease and gut microbiome found in mice – new study

Researchers may have found an unlikely contributor to the development of Alzheimer’s disease: the bacteria in your gut. Their study, published in the journal Science, suggested that certain gut bacteria increase the brain damage seen in mice with an Alzheimer’s-like disease.

The Conversation

Alzheimer's: blood biomarker may help identify the disease ten years before symptoms start

Though Alzheimer’s disease affects more than 55 million people worldwide, there’s still no cure for the condition – and treatment options are limited.

The Conversation

Vaccination to prevent dementia? New research suggests one way viral infections can accelerate neurodegeneration

One in nine Americans ages 65 and over had Alzheimer’s disease in 2022, and countless others were indirectly affected as caregivers, health care providers and taxpayers. There is currently no cure – available treatments primarily focus on prevention by encouraging protective factors, such as exercise and healthy diet, and reducing…

The Conversation

HRT ‘potentially important’ in reducing women’s dementia risk

Research suggests hormone replacement therapy may reduce risk of Alzheimer’s in some women

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

What the FDA's accelerated approval of a new Alzheimer's drug could mean for those with the disease – 5 questions answered about lecanemab

The U.S. Food and Drug Administration approved the medication lecanemab, sold under the brand name Leqembi, on Jan. 6, 2023, through an “accelerated approval pathway” that fast-tracks promising clinical treatments for diseases in which there are no other currently effective options.

The Conversation

Mayo Clinic expert provides perspective on FDA approval of another experimental Alzheimer's drug

The Food and Drug Administration granted accelerated approval of a disease-modifying treatment that could potentially give some patients with Alzheimer's disease something they haven't had before: a medication that may slow the decline of memory and thinking.

Tribune News Service

New Biomarker Test Can Identify Alzheimer's Neurodegeneration In Blood: Study

A team of neuroscientists led by a University of Pittsburgh School of Medicine researcher developed a blood test to detect a new marker of Alzheimer's disease neurodegeneration. Read on for details:

Dynamite News

New blood test developed to detect signs of Alzheimer’s disease

‘A blood test is cheaper, safer and easier to administer, and it can improve clinical confidence in diagnosing Alzheimer’s’

The Independent UK

Traumatic Brain Injury, PTSD Associated With Alzheimer's: Research

The medical profession has never before investigated the effects of traumatic brain injury (TBI), post-traumatic stress disorder (PTSD) and genetic risk factors in a sizable cohort. Read on for details:

Dynamite News

Researchers find signs of Alzheimer's disease in dolphins

Researchers in Scotland have found dolphins with classic markers of Alzheimer's disease in their brains, potentially pointing to the reason the animals became stranded.

ABC News

Lecanemab: Experimental drug is a ray of hope for Alzheimer's disease

On Nov. 30, Eisai and Biogen announced the results of their latest phase 3 clinical trial in Alzheimer’s disease. The verdict: an 18-month treatment with lecanemab slows functional and cognitive loss by 27 per cent in people with mild cognitive impairment or mild dementia due to Alzheimer’s disease. The study…

The Conversation

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Dolphins may suffer from Alzheimer’s disease, say researchers in Scotland

Bottlenose dolphin, a long-finned pilot whale and a third species found to have markers of the degenerative disease

The Independent UK

Stranded dolphins’ brains show common signs of Alzheimer’s disease – study

The findings might help explain why some species get stranded, researchers say.

The Independent UK

Dolphins may suffer brain damage similar to Alzheimer’s disease

A new study shows four animals from different dolphin species have some of the brain changes associated with human Alzheimer’s disease

The Conversation

Why does the Alzheimer's brain become insulin-resistant?

As the population ages, the number of people with neurodegenerative diseases, such as Alzheimer’s disease, increases. Approximately 75,000 Canadians are diagnosed with Alzheimer’s disease each year and experience a decline in their cognitive abilities. The ordeal usually lasts for several years while their family members watch helplessly.

Get all your
news in one place.

100's of premium titles.
One news app.

Inverse

The first study to measure vitamin D in the brain could help reveal how to maintain cognitive health

A new study found a link between higher concentrations of Vitamin D and improved cognition in aging people.

Chicago Tribune

Commentary: By sharing their genetic risks, Hemsworth, Jolie are raising awareness of testing

When actor Chris Hemsworth, aka Thor, God of Thunder, agreed to host a National Geographic series about extending the human life span, he didn’t expect to discover a genetic risk of his own. But that’s what happened as Hemsworth revealed on an episode of “Limitless” that he carries a common…

The Conversation

Harnessing the brain's immune cells to stave off Alzheimer's and other neurodegenerative diseases

Many neurodegenerative diseases, or conditions that result from the loss of function or death of brain cells, remain largely untreatable. Most available treatments target just one of the multiple processes that can lead to neurodegeneration, which may not be effective in completely addressing disease symptoms or progress, if at all.

Wales Online

Blood test could detect Alzheimer's disease years before symptoms

The new test could detect a toxic protein which has been linked to Alzheimer's disease years before any symptoms appear in the patient

The Independent UK

Blood test can detect ‘toxic’ protein years before Alzheimer’s symptoms – study

Currently patients tend to receive a diagnosis of Alzheimer’s only after they show well-known signs of the disease.

Newcastle Herald

Trial offers new hope for Alzheimer's Disease treatment

Hunter residents at high risk of developing Alzheimer's Disease will be given access to a clinical trial involving a breakthrough drug that appears to slow the development of the disease.

Wales Online

New drug is 'beginning of the end' of Alzheimer's - who will it help and when will it be available?

Lecanemab has been shown in trials to slow the progress of early-stage Alzheimer's by 27%

1 … 10 11 12 13

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

University of Edinburgh

202 stories

University of Glasgow

University of Washington

96 stories

Tufts University

90 stories

National Institutes of Health

New England Journal of Medicine

31 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.